StonvexLoading…
StonvexStonvexStonvexCore line items from SLP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-08-31 | Annual 2024 2024-08-31 | Annual 2023 2023-08-31 | Annual 2022 2022-08-31 |
|---|---|---|---|---|
Revenue | $79.18M | $70.01M | $59.58M | $53.91M |
Operating Income | $-70.73M | $6.13M | $8.72M | $14.91M |
Net Income | $-64.72M | $9.95M | $9.96M | $12.48M |
EPS (Diluted) | $-3.22 | $0.49 | $0.49 | $0.60 |
Total Assets | $131.94M | $196.64M | $186.10M | $188.38M |
Total Liabilities | $7.13M | $14.21M | $16.07M | $10.13M |
Cash & Equivalents | $30.85M | $10.31M | $57.52M | $51.57M |
Free Cash Flow OCF − CapEx | $17.41M | $12.75M | $21.40M | $17.08M |
Shares Outstanding | 20.14M | 20.05M | 19.94M | 20.26M |